Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Patterson

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Annals of Surgical Oncology|October 17, 2008
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccinesCraig L Slingluff, Galina V Yamshchikov, Kevin T Hogan, et al.
Military Medicine|September 23, 2025
Partial Resuscitative Endovascular Balloon Occlusion of the Aorta Versus Intermittent Resuscitative Endovascular Balloon Occlusion of the Aorta in Noncompressible Torso Hemorrhage With Concomitant Traumatic Brain InjuryGloria D Sanin, Elizabeth C Wood, Micaela K Gomez, et al.
Shock (Augusta, Ga.)|June 18, 2024
INVESTIGATING THE RELATIONSHIP BETWEEN BLEEDING, CLOTTING, AND COAGULOPATHY DURING AUTOMATED PARTIAL REBOA STRATEGIES IN A HIGHLY LETHAL PORCINE HEMORRHAGE MODELAntonio C Renaldo, Hebah Soudan, Micaela K Gomez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanomaKimberly A Chianese-Bullock, Jennifer Pressley, Courtney Garbee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed scheduleCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Journal of Pediatric Surgery|November 13, 2023
Transcystic Laparoscopic Common Bile Duct Exploration for Pediatric Patients with Choledocholithiasis: A Multi-Center StudyJessica Rauh, Goeto Dantes, Marshall Wallace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cellsCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Annals of Surgical Oncology|October 17, 2008
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccinesCraig L Slingluff, Galina V Yamshchikov, Kevin T Hogan, et al.
Military Medicine|September 23, 2025
Partial Resuscitative Endovascular Balloon Occlusion of the Aorta Versus Intermittent Resuscitative Endovascular Balloon Occlusion of the Aorta in Noncompressible Torso Hemorrhage With Concomitant Traumatic Brain InjuryGloria D Sanin, Elizabeth C Wood, Micaela K Gomez, et al.
Shock (Augusta, Ga.)|June 18, 2024
INVESTIGATING THE RELATIONSHIP BETWEEN BLEEDING, CLOTTING, AND COAGULOPATHY DURING AUTOMATED PARTIAL REBOA STRATEGIES IN A HIGHLY LETHAL PORCINE HEMORRHAGE MODELAntonio C Renaldo, Hebah Soudan, Micaela K Gomez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 25, 2005
MAGE-A1-, MAGE-A10-, and gp100-derived peptides are immunogenic when combined with granulocyte-macrophage colony-stimulating factor and montanide ISA-51 adjuvant and administered as part of a multipeptide vaccine for melanomaKimberly A Chianese-Bullock, Jennifer Pressley, Courtney Garbee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 16, 2004
Immunologic and clinical outcomes of vaccination with a multiepitope melanoma peptide vaccine plus low-dose interleukin-2 administered either concurrently or on a delayed scheduleCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Journal of Pediatric Surgery|November 13, 2023
Transcystic Laparoscopic Common Bile Duct Exploration for Pediatric Patients with Choledocholithiasis: A Multi-Center StudyJessica Rauh, Goeto Dantes, Marshall Wallace, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2003
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cellsCraig L Slingluff, Gina R Petroni, Galina V Yamshchikov, et al.
Pageof 13